Non disponible en dehors du Royaume-Uni et de l'Irlande
Biochem/physiol Actions
8-20 pg/ml as measured in a cell proliferation assay with a factor-dependent murine plasmacytoma cell line, B9.
General description
Recombinant, human, interleukin-6 expressed in E. coli. Interleukin-6 is a protein produced by a number of cell types including T-lymphocytes, monocytes, diploid fibroblasts, hepatocytes, cardiac myxomas, certain cervical cancer cells, bladder cell carcinomas, vascular endothelial cells, and human myelomas. It has a variety of biological effects and does not show a high degree of species specificity. Stimulates the production of acute phase proteins by hepatocytes. Also known to induce skeletal muscle protein breakdown. Induces growth and differentiation of B-cells, T-cells, and hepatocytes. Stimulates growth and inhibits constitutive protein synthesis-independent apoptosis of murine B-cell hybridoma 7TD1. Human sequence IL-6 is active on murine cells. 1 µg is equivalent to 7.0 x 103 WHO units.
Recombinant, human, interleukin-6 expressed in E. coli. A prototypic pleiotrophic, pro-inflammatory cytokine that stimulates the production of acute phase proteins by hepatocytes. Also known to induce skeletal muscle protein breakdown. Induces growth and differentiation of B cells, T cells, and hepatocytes. Stimulates growth and inhibits constitutive, protein synthesis-independent apoptosis of murine B cell hybridoma 7TD1. IL-6 is produced by macrophages, endothelial cells, and activated T helper cells. Also considered as a potential marker of adipocyte differentiation. Human IL-6 is active on murine cells.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes
Vicennati, V., et al. 2002. Int. J. Obes. Relat. Metab. Disord.26, 9.Vallieres, L., and Rivest, S. 1999. Endocrinology140, 3890.Goodman, M.N. 1994. Proc. Soc. Exp. Biol. Med. 205, 182.Liu, J., et al. 1994. Cell Immunol.155, 229.Van Snick, J. 1990. Annu. Rev. Immunol.8, 253.
Packaging
10 µg in Plastic ampoule
Physical form
Carrier free.
Reconstitution
Following reconstitution, aliquot and freeze (-70°C). Stock solutions are stable for up to 3 months at -70°C. Avoid freeze/thaw cycles of solutions.
Reconstitute to 0.1-1.0 mg/ml in 100 mM acetic acid.
Warning
Toxicity: Standard Handling (A)
Ce produit répond aux critères suivants: